New Triple-Threat treatment tested for tough colon cancers
NCT ID NCT06784947
Summary
This study is testing whether a combination of three immunotherapy drugs can help control advanced colorectal cancer that has stopped responding to standard chemotherapy. It is for adults whose cancer has spread and has a specific genetic profile called 'microsatellite stable.' The main goal is to see if this new treatment approach can shrink tumors and is safe for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER (CRC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Universtiy of Colorado Hospital
Aurora, Colorado, 80045, United States
Conditions
Explore the condition pages connected to this study.